中华创伤杂志(英文版)2024,Vol.27Issue(2) :63-70.DOI:10.1016/j.cjtee.2023.11.001

Clinical practice of sepsis-induced immunosuppression:Current immunotherapy and future options

Fei Pei Bin Gu Shu-Min Miao Xiang-Dong Guan Jian-Feng Wu
中华创伤杂志(英文版)2024,Vol.27Issue(2) :63-70.DOI:10.1016/j.cjtee.2023.11.001

Clinical practice of sepsis-induced immunosuppression:Current immunotherapy and future options

Fei Pei 1Bin Gu 1Shu-Min Miao 1Xiang-Dong Guan 1Jian-Feng Wu1
扫码查看

作者信息

  • 1. Department of Critical Care Medicine,The First Affiliated Hospital,Sun Yat-sen University,Guangzhou,510080,China;Guangdong Clinical Research Center for Critical Care Medicine,Guangzhou,510080,China
  • 折叠

Abstract

Sepsis is a potentially fatal condition characterized by the failure of one or more organs due to a disordered host response to infection.The development of sepsis is closely linked to immune dysfunc-tion.As a result,immunotherapy has gained traction as a promising approach to sepsis treatment,as it holds the potential to reverse immunosuppression and restore immune balance,thereby improving the prognosis of septic patients.However,due to the highly heterogeneous nature of sepsis,it is crucial to carefully select the appropriate patient population for immunotherapy.This review summarizes the current and evolved treatments for sepsis-induced immunosuppression to enhance clinicians'under-standing and practical application of immunotherapy in the management of sepsis.

Key words

Sepsis/Sepsis-induced immunosuppression/Immunotherapy/Enrichment/Classifier

引用本文复制引用

基金项目

国家自然科学基金(82302415)

国家自然科学基金(82272186)

国家自然科学基金(82002076)

广东省自然科学基金(2016A030313269)

Sun Yatsen University Clinical Research Program 5010(2019002)

Guangdong Clinical Research Center for Critical Care Medicine(2020B1111170005)

出版年

2024
中华创伤杂志(英文版)
中华医学会

中华创伤杂志(英文版)

CSTPCD
影响因子:0.608
ISSN:1008-1275
参考文献量117
段落导航相关论文